Chetan Kajavadara

Employment

• Zydus Research Centre, Zydus Lifesciences Limited Sr. Scientist
  2007 - Present

Education

• Zydus Research Centre M.sc.
  2005 - 2007

Projects & Funding

Projects & funding information is unavailable.

Publications (8)

• Evaluating Solvent Safety in Chromosome Aberration Assays for Genetic Toxicology
  Journal of Applied Toxicology 2026 DOI: 10.1002/jat.4894
  +Save
• Strain-specific mutagenicity of NDMA and CPNP: insights from TA1535, TA100, and WP2 uvrA (pKM101) under metabolic activation
  Environmental Toxicology and Pharmacology 2025 DOI: 10.1016/j.etap.2025.104752
  +Save
• Comparative Analysis of TA102 and WP2uvrA(pKM101) Strains in Detecting Nitrosamine Mutagens in the Enhanced Ames Test
  Environmental and Molecular Mutagenesis 2025 DOI: 10.1002/em.70018
  +Save
• Investigating the Genotoxic Potential of Pioglitazone in Hyperglycemic Conditions Using Chromosome Aberration and GADD45α Markers in TK6 Cells
  Journal of Biochemical and Molecular Toxicology 2025 DOI: 10.1002/jbt.70332
  +Save
• Assessing the impact of different solvents in the bacterial reverse mutation test
  Environmental and Molecular Mutagenesis 2025 DOI: 10.1002/em.22649
  +Save
• Selection of solvent and positive control concentration for enhanced Ames test conditions for N-nitrosamine compounds
  Regulatory Toxicology and Pharmacology 2024 DOI: 10.1016/j.yrtph.2024.105711
  +Save
• HIF-PHD inhibitor desidustat ameliorates iron deficiency anemia
  Toxicology and Applied Pharmacology 2024 DOI: 10.1016/j.taap.2024.116832
  +Save
• Prolyl hydroxylase inhibitor desidustat improves anemia in erythropoietin hyporesponsive state
  Current Research in Pharmacology and Drug Discovery 2022 DOI: 10.1016/j.crphar.2022.100102
  +Save